Crossmark

The role of methylation quantification of circulating tumor DNA (ctDNA) as a diagnostic biomarker of Pheochromocytomas (PCCs) and Paragangliomas (PGLs)

Crossref DOI link: https://doi.org/10.1007/s40200-024-01466-8

Published Online: 2024-07-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khatami, Fatemeh

Reis, Leonardo Oliveira

Ebrahimi, Mehdi

Nasiri, Shirzad

Tavangar, Seyed Mohammad

Pishkuhi, Mahin Ahmadi

Shafiee, Gita

Heshmat, Ramin

Aghamir, Seyed Mohammad Kazem https://orcid.org/0000-0003-1611-0362
Funding

Funding for this research was provided by:

National Institute for Medical Research Development (977079)
License Information

Text and Data Mining valid from 2024-07-20

Version of Record valid from 2024-07-20
More Information

Article History

Received: 18 May 2024

Accepted: 2 July 2024

First Online: 20 July 2024

Declarations

:

: All procedures approved by National Institute for Medical Science Development Ethics Committee (IR.NIMAD.REC.1397.452).

: All patients signed the informed consent for publishing result of the study anonymously.

: All authors declare there is not any conflict of interest for this publication.

Document is current

Any future updates will be listed below